• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

T cells and ILC2s are major effector cells in influenza-induced exacerbation of allergic airway inflammation in mice

tetano

Editor, Senior Moderator
Eur J Immunol. 2018 May 15. doi: 10.1002/eji.201747421. [Epub ahead of print]
[h=1]T cells and ILC2s are major effector cells in influenza-induced exacerbation of allergic airway inflammation in mice.[/h] W S Li B[SUP]1[/SUP], J W de Bruijn M[SUP]1[/SUP], Lukkes M[SUP]1[/SUP], van Nimwegen M[SUP]1[/SUP], M Bergen I[SUP]1[/SUP], KleinJan A[SUP]1[/SUP], H GeurtsvanKessel C[SUP]2[/SUP], Andeweg A[SUP]2[/SUP], F Rimmelzwaan G[SUP]2[/SUP], W Hendriks R[SUP]1[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] Influenza virus infection is an important cause of severe asthma exacerbations, but it remains unclear how a Th1-mediated antiviral response triggers a prototypical Th2 disease. We investigated CD4[SUP]+[/SUP] T cells and group 2 innate lymphoid cells (ILC2s) in influenza virus-infected mice. We found that ILC2s accumulated in the lung rapidly after influenza virus infection, but the induction of IL-5 and IL-13 secretion was delayed and concomitant with T cell activation. In an influenza-induced exacerbation of allergic airway inflammation model we noticed an initial reduction of ILC2 numbers and cytokine production in broncho-alveolar lavage compared to chronic house dust mite (HDM)-mediated airway inflammation alone. ILC2s phenotype was characterized by low T1/ST2, ICOS, KLRG1 and CD25 expression, resembling na?ve ILC2s. The contribution of ILC2s to type 2 cytokine production in the early stage of the influenza-induced exacerbation was limited. In contrast, T cells showed increased IL-4 and IL-5 production when exposed to both HDM and influenza virus. Upon virus clearance, ILC2s regained an activated T1/ST2[SUP]high[/SUP] ICOS[SUP]high[/SUP] KLRG1[SUP]high[/SUP] CD25[SUP]high[/SUP] phenotype paired with cytokine production and were major contributors to the type 2 cytokine milieu. Collectively, our data indicate that both T cells and ILC2s contribute to influenza-induced exacerbation of allergic airway inflammation, but with different kinetics. This article is protected by copyright. All rights reserved.


[h=4]KEYWORDS:[/h] Allergic airway inflammation; Allergy; Exacerbation; ILC2; Influenza virus

PMID: 29762870 DOI: 10.1002/eji.201747421
 
Back
Top Bottom